SUMMARYmay involve differences in physical constitution (body water space, muscle mass, organ blood flow and organ In this review I have attempted to summarize gender function) and physiology (menopause, pregnancy and differences in pharmacokinetics involving the cytomenstruation) between women and men. In addition, chrome P450 (CYP) isozymes of young and mature as hormonal steroid contraceptives are used by some adults, excluding the effects of the menstrual cycle, women, therapeutic drugs for use by pregnant women, use of oral contraceptives and pregnancy. Sex difin particular, should be restricted because of obvious ferences in drug metabolism and elimination are ethical considerations other than age. Thus, the pharmainly related to steroid hormone levels. CYP3A4, macokinetics and pharmacodynamics of many drugs responsible for the metabolism of over 50% of theramay well be different due to a variety of causal factors peutic drugs, exhibits higher activity in women than (Fig. 1). in men. Nonetheless, the absence of a sex difference Cytochrome P450 (P450 or CYP) is involved in drug has been reported by some workers. The activity metabolism, but can be divided into many subfamilies, of several other CYP (CYP2C19, CYP2D6, CYP2E1) e.g. CYP1A2, 2C9, 2C19, 2D6, 2E1, 3A4, each of which isozymes and the conjugation (glucuronidation) is linked to a different set of drugs, and numerous activity involved in drug metabolism may be higher reviews have been published on this topic (8-26). Some in men than in women. Drug metabolism in women drugs, such as S-mephenytoin, catalysed by CYP2C19 is affected by sex-specific factors (menopause, pregnancy and menstruation) in addition to the cigarette smoking, drug ingestion and alcohol consumption that are more commonly observed factors in men. Furthermore, they are affected by physiological factors such as drug absorption, protein binding and elimination. Thus, careful attention should be paid to the side-effects and toxicity arising from sex differences in drug metabolism in clinical situations. Although there are specific ethical considerations regarding carrying out drug trials in women, the relationship between the side-effects and toxicity that may be influenced by hormones during drug metabolism and drug treatment needs further study.